No IPOs are currently scheduled in the week ahead, as ongoing geopolitical uncertainties continue to rattle investors, although some smaller issuers may join the calendar throughout the week. While activity may remain quiet in the coming weeks, several...read more
Two IPOs, one direct listing, and three SPACs came to the market this past week, and one major issuer joined the pipeline. PayPay (PAYP) priced its IPO below the range to raise $880 million at a $10.8 billion diluted market cap. Backed by SoftBank, PayPay is ...read more
JATT II Acquisition, a blank check company targeting biotechs and life sciences businesses, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The company plans to raise $60 million by offering 6 million shares at $10. The...read more
US IPO Week Ahead: No IPOs scheduled as Iran war fallout continues to weigh on markets
No IPOs are currently scheduled in the week ahead, as ongoing geopolitical uncertainties continue to rattle investors, although some smaller issuers may join the calendar throughout the week. While activity may remain quiet in the coming weeks, several...read more
US IPO Weekly Recap: PayPay prices US IPO below the range but climbs 32%
Two IPOs, one direct listing, and three SPACs came to the market this past week, and one major issuer joined the pipeline. PayPay (PAYP) priced its IPO below the range to raise $880 million at a $10.8 billion diluted market cap. Backed by SoftBank, PayPay is ...read more
SPAC JATT II Acquisition files for a $60 million IPO, targeting biotech and life sciences
JATT II Acquisition, a blank check company targeting biotechs and life sciences businesses, filed on Friday with the SEC to raise up to $60 million in an initial public offering. The company plans to raise $60 million by offering 6 million shares at $10. The...read more